On 26 November 2010, orphan designation (EU/3/10/808) was granted by the European Commission to ADIENNE S.r.l., Italy, for murine monoclonal antibody against CD26 for the treatment of graft-versus-host disease.
In January 2014, ADIENNE S.r.l. changed name to ADIENNE S.r.l.S.U.
For a list of the administrative updates to this public summary of opinion please refer to the PDF document below.
Murine monoclonal antibody against CD26
|Disease / condition||
Treatment of graft-versus-host disease
|Date of decision||
|Orphan decision number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
- Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;
- European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.